• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HCV 微消除策略:一项针对未获得系统治疗的确诊患者的干预性研究。

HCV microelimination strategies: An interventional study in diagnosed patients without access to the system.

机构信息

Gastroenterology and Hepatology Department, Virgen Macarena University Hospital, Seville, Spain.

Gastroenterology Department, Virgen Macarena University Hospital, Seville, Spain.

出版信息

Liver Int. 2021 May;41(5):928-933. doi: 10.1111/liv.14824. Epub 2021 Mar 8.

DOI:10.1111/liv.14824
PMID:33587789
Abstract

Hepatitis C virus (HCV) one-step diagnosis improves recovery in patients with active infection. However, patients with previous anti-HCV+ may be excluded. We aimed to identify and retrieve non-referred or lost-to-follow-up HCV-infected patients. All anti-HCV+ patients seen in our hospital between 2013 and 2018 were included. In the first phase, we identified anti-HCV+ patients who were not referred to the Gastroenterology Unit (GU) or lost-to-follow-up. In the second phase, recovered patients were invited for a one-step visit for liver evaluation. A total of 1330 anti-HCV+ patients were included: 21.7% had not been referred to GU, and 23.1% were lost-to-follow-up. In the second phase, 49.6% of patients were contacted, and 92.8% attended a medical consultation: 62.7% had active infection, 92.2% were treated, and 86.5% achieved SVR (ITT). We concluded that screening microbiological data and referring unidentified patients with active HCV infection directly to specialists is an effective tool in achieving HCV microelimination.

摘要

丙型肝炎病毒 (HCV) 一步诊断可提高活动性感染患者的康复率。然而,既往抗-HCV+的患者可能会被排除在外。我们旨在发现和检索未转诊或失访的 HCV 感染患者。我们纳入了 2013 年至 2018 年期间在我院就诊的所有抗-HCV+患者。在第一阶段,我们确定了未转诊至胃肠病科(GU)或失访的抗-HCV+患者。在第二阶段,我们邀请康复患者进行一步就诊以进行肝脏评估。共纳入 1330 例抗-HCV+患者:21.7%未转诊至 GU,23.1%失访。在第二阶段,我们联系了 49.6%的患者,92.8%的患者参加了医疗咨询:62.7%的患者有活动性感染,92.2%的患者接受了治疗,86.5%的患者达到了 SVR(ITT)。我们得出结论,筛查微生物数据并将未识别的活动性 HCV 感染患者直接转诊给专家是实现 HCV 消除的有效工具。

相似文献

1
HCV microelimination strategies: An interventional study in diagnosed patients without access to the system.HCV 微消除策略:一项针对未获得系统治疗的确诊患者的干预性研究。
Liver Int. 2021 May;41(5):928-933. doi: 10.1111/liv.14824. Epub 2021 Mar 8.
2
Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.丙型肝炎微消除系统中失访患者的找回:一项单中心回顾性研究。
BMC Gastroenterol. 2021 May 8;21(1):209. doi: 10.1186/s12876-021-01792-8.
3
Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in the Netherlands.荷兰失访的既往慢性丙型肝炎感染的检索和再评估。
Eur J Gastroenterol Hepatol. 2020 Jul;32(7):851-856. doi: 10.1097/MEG.0000000000001593.
4
Public Health Unit notifications of hepatitis C and their follow-up in South Western Sydney, Australia.澳大利亚西南悉尼公共卫生单位的丙型肝炎通知及其后续情况。
Public Health Res Pract. 2021 Sep 8;31(3):30342010. doi: 10.17061/phrp30342010.
5
One-step diagnosis strategy together with multidisciplinary telematics referral perform an effective approach for identifying and treating patients with active Hepatitis C infection.一步诊断策略与多学科远程信息转诊相结合,为识别和治疗活动性丙型肝炎感染患者提供了一种有效的方法。
Ann Hepatol. 2022 Jan-Feb;27(1):100542. doi: 10.1016/j.aohep.2021.100542. Epub 2021 Sep 24.
6
Retrieval of HCV patients lost to follow-up as a strategy for Hepatitis C Microelimination: results of a Brazilian multicentre study.作为丙型肝炎微消除策略的失访 HCV 患者检索:巴西多中心研究的结果。
BMC Infect Dis. 2023 Jul 13;23(1):468. doi: 10.1186/s12879-023-08169-0.
7
Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C.荷兰丙型肝炎消除(CELINE):全国性检索慢性丙型肝炎失访患者的研究方案。
BMJ Open Gastroenterol. 2020 Apr 12;7(1):e000396. doi: 10.1136/bmjgast-2020-000396. eCollection 2020.
8
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination.全球通过微消除策略实现丙型肝炎消除努力的系统评价。
Semin Liver Dis. 2022 May;42(2):159-172. doi: 10.1055/a-1777-6112. Epub 2022 Feb 21.
9
Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?男性艾滋病病毒感染者中丙型肝炎病毒发病率下降:英国实现丙型肝炎病毒微消除的进展?
Clin Infect Dis. 2021 Jan 27;72(2):233-238. doi: 10.1093/cid/ciaa021.
10
[The impact of direct-acting antiviral therapy on the diagnosis of hepatitis-C virus-associated hepatocellular carcinoma].[直接抗病毒治疗对丙型肝炎病毒相关肝细胞癌诊断的影响]
Nihon Shokakibyo Gakkai Zasshi. 2018;115(2):184-194. doi: 10.11405/nisshoshi.115.184.

引用本文的文献

1
Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up.通过对失访患者的检索策略实现丙型肝炎的消灭目标。
BMC Gastroenterol. 2023 Feb 13;23(1):40. doi: 10.1186/s12876-023-02665-y.
2
Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis.用于未确定或混合基因型丙型肝炎感染的泛基因型直接抗病毒药物:一项真实世界多中心疗效分析
J Clin Med. 2022 Mar 27;11(7):1853. doi: 10.3390/jcm11071853.
3
Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.
丙型肝炎微消除系统中失访患者的找回:一项单中心回顾性研究。
BMC Gastroenterol. 2021 May 8;21(1):209. doi: 10.1186/s12876-021-01792-8.